Skip to main content

Farletuzumab (MORAb-003) in platinum-sensitive ovarian cancer patients experiencing a first relapse

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Farletuzumab (MORAb-003) in platinum-sensitive ovarian cancer patients experiencing a first relapse

User login

Username

Password

Reset your password

Type	Lead	score